Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.

Gallery M, Zhang J, Bradley DP, Brauer P, Cvet D, Estevam J, Danaee H, Greenfield E, Li P, Manfredi M, Loke HK, Rabino C, Stringer B, Williamson M, Wyant T, Yang J, Zhu Q, Abu-Yousif A, Veiby OP.

PLoS One. 2018 Jan 25;13(1):e0191046. doi: 10.1371/journal.pone.0191046. eCollection 2018.

2.

Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors.

Pronk CJ, Veiby OP, Bryder D, Jacobsen SE.

J Exp Med. 2011 Aug 1;208(8):1563-70. doi: 10.1084/jem.20110752. Epub 2011 Jul 18.

3.

Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors.

Gould AE, Adams R, Adhikari S, Aertgeerts K, Afroze R, Blackburn C, Calderwood EF, Chau R, Chouitar J, Duffey MO, England DB, Farrer C, Forsyth N, Garcia K, Gaulin J, Greenspan PD, Guo R, Harrison SJ, Huang SC, Iartchouk N, Janowick D, Kim MS, Kulkarni B, Langston SP, Liu JX, Ma LT, Menon S, Mizutani H, Paske E, Renou CC, Rezaei M, Rowland RS, Sintchak MD, Smith MD, Stroud SG, Tregay M, Tian Y, Veiby OP, Vos TJ, Vyskocil S, Williams J, Xu T, Yang JJ, Yano J, Zeng H, Zhang DM, Zhang Q, Galvin KM.

J Med Chem. 2011 Mar 24;54(6):1836-46. doi: 10.1021/jm101479y. Epub 2011 Feb 22.

PMID:
21341678
4.

Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.

Chakravarty A, Shinde V, Tabernero J, Cervantes A, Cohen RB, Dees EC, Burris H, Infante JR, Macarulla T, Elez E, Andreu J, Rodriguez-Braun E, Rosello S, von Mehren M, Meropol NJ, Langer CJ, ONeil B, Bowman D, Zhang M, Danaee H, Faron-Yowe L, Gray G, Liu H, Pappas J, Silverman L, Simpson C, Stringer B, Tirrell S, Veiby OP, Venkatakrishnan K, Galvin K, Manfredi M, Ecsedy JA.

Cancer Res. 2011 Feb 1;71(3):675-85. doi: 10.1158/0008-5472.CAN-10-1030. Epub 2010 Dec 10.

5.

Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis.

Schmelzle T, Mailleux AA, Overholtzer M, Carroll JS, Solimini NL, Lightcap ES, Veiby OP, Brugge JS.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3787-92. Epub 2007 Feb 26.

7.

Effects of hTNFalpha expression in T cells on haematopoiesis in transgenic mice.

Glosli H, Veiby OP, Fjerdingstad H, Mehlum A, Probert L, Kollias G, Gjernes E, Prydz H.

Eur J Haematol. 1999 Jul;63(1):50-60.

PMID:
10414455
8.

Growth factors and hematopoietic stem cells.

Veiby OP, Mikhail AA, Snodgrass HR.

Hematol Oncol Clin North Am. 1997 Dec;11(6):1173-84. Review.

PMID:
9443050
10.

Mannuronan enhances survival of lethally irradiated mice and stimulates murine haematopoiesis in vitro.

Halaas O, Olsen WM, Veiby OP, Løvhaug D, Skjåk-Braek G, Vik R, Espevik T.

Scand J Immunol. 1997 Oct;46(4):358-65.

11.

Transforming growth factor-beta1 abrogates Fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells.

Dybedal I, Guan F, Borge OJ, Veiby OP, Ramsfjell V, Nagata S, Jacobsen SE.

Blood. 1997 Nov 1;90(9):3395-403.

PMID:
9345022
12.
13.

Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells.

Sindre H, Tjøonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degré M, Hestdal K.

Blood. 1996 Dec 15;88(12):4526-33.

PMID:
8977244
15.

Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro.

Borge OJ, Ramsfjell V, Veiby OP, Murphy MJ Jr, Lok S, Jacobsen SE.

Blood. 1996 Oct 15;88(8):2859-70.

PMID:
8874182
17.

Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit.

Barstad RM, Ovrum E, Ringdal MA, Oystese R, Hamers MJ, Veiby OP, Rolfsen T, Stephens RW, Sakariassen KS.

Br J Haematol. 1996 Sep;94(3):517-25.

PMID:
8790153
19.

TNF-alpha bidirectionally modulates the viability of primitive murine hematopoietic progenitor cells in vitro.

Jacobsen FW, Veiby OP, Stokke T, Jacobsen SE.

J Immunol. 1996 Aug 1;157(3):1193-9.

PMID:
8757625
20.

Lineage commitment of CD34+ human hematopoietic progenitor cells.

Tjønnfjord GE, Steen R, Veiby OP, Egeland T.

Exp Hematol. 1996 Jul;24(8):875-82.

PMID:
8690045
22.

Inhibition of enriched stem cells in vivo and in vitro by the hemoregulatory peptide SK&F108636.

Veiby OP, LoCastro S, Bhatnagar P, Olsen WM.

Stem Cells. 1996 Mar;14(2):215-24.

23.
24.

The effect of strenuous exercise, calorie deficiency and sleep deprivation on white blood cells, plasma immunoglobulins and cytokines.

Bøyum A, Wiik P, Gustavsson E, Veiby OP, Reseland J, Haugen AH, Opstad PK.

Scand J Immunol. 1996 Feb;43(2):228-35.

PMID:
8633203
25.

Thrombopoietin, a direct stimulator of viability and multilineage growth of primitive bone marrow progenitor cells.

Jacobsen SE, Borge OJ, Ramsfjell V, Cui L, Cardier JE, Veiby OP, Murphy MJ Jr, Lok S.

Stem Cells. 1996;14 Suppl 1:173-80. Review.

26.

Haemopoietic progenitor cell differentiation: flow cytometric assessment in bone marrow and thymus.

Tjønnfjord GE, Steen R, Veiby OP, Mørkrid L, Egeland T.

Br J Haematol. 1995 Dec;91(4):1006-16.

PMID:
8547112
27.

Direct synergistic effects of IL-4 and IL-11 on proliferation of primitive hematopoietic progenitor cells.

Jacobsen FW, Keller JR, Ruscetti FW, Veiby OP, Jacobsen SE.

Exp Hematol. 1995 Aug;23(9):990-5.

PMID:
7543420
30.
31.

Thymic stromal cells support differentiation of natural killer cells from CD34+ bone marrow cells in vitro.

Tjønnfjord GE, Steen R, Veiby OP, Egeland T.

Eur J Haematol. 1995 Jan;54(1):46-50.

PMID:
7532139
32.
33.

Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis.

Jacobsen FW, Rothe M, Rusten L, Goeddel DV, Smeland EB, Veiby OP, Slørdal L, Jacobsen SE.

Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10695-9.

34.

Distinct and direct synergistic effects of IL-1 and IL-6 on proliferation and differentiation of primitive murine hematopoietic progenitor cells in vitro.

Jacobsen SE, Ruscetti FW, Okkenhaug C, Lien E, Ortiz M, Veiby OP, Keller JR.

Exp Hematol. 1994 Oct;22(11):1064-9.

PMID:
7925772
36.

Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.

Rusten LS, Jacobsen SE, Kaalhus O, Veiby OP, Funderud S, Smeland EB.

Blood. 1994 Sep 1;84(5):1473-81.

PMID:
7520773
37.

Stem cell factor and interleukin-7 synergize to enhance early myelopoiesis in vitro.

Fahlman C, Blomhoff HK, Veiby OP, McNiece IK, Jacobsen SE.

Blood. 1994 Sep 1;84(5):1450-6.

PMID:
7520772
38.
39.

Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells.

Jacobsen SE, Okkenhaug C, Veiby OP, Caput D, Ferrara P, Minty A.

J Exp Med. 1994 Jul 1;180(1):75-82.

40.

Novel role of interleukin 7 in myelopoiesis: stimulation of primitive murine hematopoietic progenitor cells.

Jacobsen FW, Veiby OP, Skjønsberg C, Jacobsen SE.

J Exp Med. 1993 Nov 1;178(5):1777-82.

41.
42.

T lymphocyte differentiation in vitro from adult human prethymic CD34+ bone marrow cells.

Tjønnfjord GE, Veiby OP, Steen R, Egeland T.

J Exp Med. 1993 Jun 1;177(6):1531-9.

43.

Indirect stimulation of hemopoiesis by hemoregulatory peptide (HP5b) dimer in murine long-term bone marrow cultures.

Veiby OP, Løvhaug D, Fjerdingstad H, Engelsen SJ.

Exp Hematol. 1992 Feb;20(2):192-5.

PMID:
1544388
44.

Amino acid sequence analyses of non-AA proteins from amyloid fibrils of bovine kidney.

Veiby OP, Sletten K, Husby G, Nordstoga K.

Scand J Immunol. 1992 Jan;35(1):63-9.

PMID:
1734497
45.

Responses of normal and rheumatic human articular chondrocytes cultured under various experimental conditions in agarose.

Ostensen M, Veiby OP, Raiss R, Hagen A, Pahle J.

Scand J Rheumatol. 1991;20(3):172-82.

PMID:
2068539

Supplemental Content

Loading ...
Support Center